Literature DB >> 9935155

Selective increase of alpha2-integrin sub-unit expression on human carcinoma cells upon EGF-receptor activation.

K Krensel1, R B Lichtner.   

Abstract

The effects of chronic EGF exposure on expression of the alpha2beta1 collagen and alpha5beta1 fibronectin receptor in a pair of human carcinoma cell lines (A431 and A549) with differential responses to EGF in a short-term ECM-cell adhesion assay were investigated. Treatment with EGF at 10 ng/ml for 24 hr increased on both cell lines the expression of the alpha2- but not the beta1- or alpha5-integrin sub-units, and concomitantly cellular adhesion was increased on collagen IV but not on fibronectin. Increased collagen adhesion of A549 cells could be blocked by alpha2- and beta1-integrin-sub-unit antibodies down to control levels, while it was blocked by alpha2-integrin-sub-unit antibody only by 60% and completely by the beta1-integrin-sub-unit antibody on A431 cells. EGF induced disparate shifts in cell morphologies (dome-like structures, A431, vs. spindle-like fibroblastoid, A549) with concomitant opposite changes in the expression/localization of E-cadherin in cell-cell contacts. This could be taken as an indication for cell-type-specific differential changes in the ratio of cell-ECM vs. cell-cell contacts. The EGF-induced up-regulation of the alpha2beta1 integrin was instrumental in increasing collagen adhesion of A549 but only partly in the case of A431 cells, in which cells the alpha2beta1 integrin may have additional functions besides serving as cell-ECM receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9935155     DOI: 10.1002/(sici)1097-0215(19990209)80:4<546::aid-ijc11>3.0.co;2-9

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness.

Authors:  Xue Li; Seiichiro Ishihara; Motoaki Yasuda; Takeshi Nishioka; Takeomi Mizutani; Masayori Ishikawa; Kazushige Kawabata; Hiroki Shirato; Hisashi Haga
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

2.  Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models.

Authors:  Ken Ito; Taro Semba; Toshimitsu Uenaka; Toshiaki Wakabayashi; Makoto Asada; Yasuhiro Funahashi
Journal:  Cancer Sci       Date:  2014-08       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.